This federal contract award, valued at $6,915.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10 mL vials of the Typhim VI vaccine, which is used for the prevention of meningococcal disease. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role in supplying essential medical products to various government agencies, including the military and veterans' healthcare systems.
Generated 3/5/25, 10:06 AM